Micronutrients Supplementation in Pregnant Women during COVID-19 Pandemy: Pros and Cons

Document Type : Review Article

Authors

1 Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

2 Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

3 Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Abstract

Coronavirus can negatively affect the immune system. This complication can be exaggerated in pregnant women with micronutrient and elemental deficiencies. Also, coronavirus itself can induce micronutrients malabsorption and result in their severe deficiencies that can lead to increased risk of infection in these groups of patients. Serum calcium, zinc, iron, and selenium values have a positive correlation with PO2 values and a negative correlation with severe COVID-19 infection, lung involvement, fever, and C-reactive protein (CRP) concentration. In this mini-review study, the safety and efficacy of different suggested micronutrients including zinc, selenium, iron, vitamin A, C, D, E, and myo-inositol in pregnant women with COVID-19 have been discussed. According to the clinical practice findings and previous reports, administration of essential micronutrients including zinc, selenium, and iron and vitamins including vitamin A, B8, C, D, and E with optimum recommended dietary allowances (RDAs) during pregnancy would be promising and suggestive to improve maternal/neonatal complications during COVID-19 infection due to the enhanced immunity system against viral infection and COVID-19 pneumonia.

Keywords

References

1. Ghasemiyeh P, Mohammadi-Samani S. COVID-19 outbreak: Challenges in pharmacotherapy based on pharmacokinetic and pharmacodynamic aspects of drug therapy in patients with moderate to severe infection. Heart Lung. 2020 Nov-Dec;49(6):763-773. doi: 10.1016/j.hrtlng.2020.08.025. Epub 2020 Sep 18. PMID: 32980626; PMCID: PMC7500907.
2. Ghasemiyeh P, Borhani-Haghighi A, Karimzadeh I, et al. Major Neurologic Adverse Drug Reactions, Potential Drug-Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review. Ther Clin Risk Manag. 2020;16:595-605. Published 2020 Jun 30. doi:10.2147/TCRM.S259152
3. Ghasemiyeh P, Mohammadi-Samani S. Iron Chelating Agents: Promising Supportive Therapies in Severe Cases of COVID-19? Trends in Pharmaceutical Sciences. 2020;6(2):65-6.
4. Ghasemiyeh P, Mohammadi-Samani S. The necessity of early anti-inflammatory therapy initiation in cases with mild-to-moderate COVID-19: A personal experience from an attending pharmacist and his resident. Acta Biomed. 2021 Jul 1;92(3):e2021250. doi: 10.23750/abm.v92i3.11683. PMID: 34212899.
5. Skalny AV, Timashev PS, Aschner M, Aaseth J, Chernova LN, Belyaev VE, et al. Serum Zinc, Copper, and Other Biometals Are Associated with COVID-19 Severity Markers. Metabolites. 2021 Apr 15;11(4):244. doi: 10.3390/metabo11040244. PMID: 33920813; PMCID: PMC8071197.
6. Nawsherwan, Khan S, Zeb F, Shoaib M, Nabi G, Ul Haq I, et al. Selected Micronutrients: An Option to Boost Immunity against COVID-19 and Prevent Adverse Pregnancy Outcomes in Pregnant Women: A Narrative Review. Iran J Public Health. 2020 Nov;49(11):2032-2043. doi: 10.18502/ijph.v49i11.4717. PMID: 33708724; PMCID: PMC7917498.
7. Calder PC. Nutrition, immunity and COVID-19. BMJ Nutr Prev Health. 2020 May 20;3(1):74-92. doi: 10.1136/bmjnph-2020-000085. PMID: 33230497; PMCID: PMC7295866.
8. Soprano DR, Soprano KJ. Retinoids as teratogens. Annu Rev Nutr. 1995;15:111-32. doi: 10.1146/annurev.nu.15.070195.000551. PMID: 8527214.
9. Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. N Engl J Med. 1995 Nov 23;333(21):1369-73. doi: 10.1056/NEJM199511233332101. PMID: 7477116.
10. [June 2021]. Available from: https://www.lib.utdo.ir/contents/search.
11. Milani GP, Macchi M, Guz-Mark A. Vitamin C in the Treatment of COVID-19. Nutrients. 2021; 13(4):1172. https://doi.org/10.3390/nu13041172
12. Rumbold A, Crowther CA. Vitamin C supplementation in pregnancy. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004072. doi: 10.1002/14651858.CD004072.pub2. Update in: Cochrane Database Syst Rev. 2015;9:CD004072. PMID: 15846696.
13. Bezerra Espinola MS, Bertelli M, Bizzarri M, Unfer V, Laganà AS, et al. Inositol and vitamin D may naturally protect human reproduction and women undergoing assisted reproduction from Covid-19 risk. J Reprod Immunol. 2021 Apr;144:103271. doi: 10.1016/j.jri.2021.103271. Epub 2021 Jan 8. PMID: 33493945; PMCID: PMC7833496.
14. Alam MS, Czajkowsky DM, Islam MA, Rahman MA. The role of vitamin D in reducing SARS-CoV-2 infection: An update. Int Immunopharmacol. 2021:107686.
15. COVID-19 rapid guideline: vitamin D [cited 2021 June]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK566063/.
16. Shakoor H, Feehan J, Al Dhaheri AS, Ali HI, Platat C, Ismail LC, et al. Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19? Maturitas. 2021 Jan;143:1-9. doi: 10.1016/j.maturitas.2020.08.003. Epub 2020 Aug 9. PMID: 33308613; PMCID: PMC7415215.
17. Rumbold A, Crowther CA. Vitamin E supplementation in pregnancy. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004069. doi: 10.1002/14651858.CD004069.pub2. Update in: Cochrane Database Syst Rev. 2015;9:CD004069. PMID: 15846695.
18. Formoso G, Baldassarre MPA, Ginestra F, Carlucci MA, Bucci I, Consoli A. Inositol and antioxidant supplementation: Safety and efficacy in pregnancy. Diabetes Metab Res Rev. 2019;35(5):e3154. doi:10.1002/dmrr.3154
19. Habib HM, Ibrahim S, Zaim A, Ibrahim WH. The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators. Biomed Pharmacother. 2021 Apr;136:111228. doi: 10.1016/j.biopha.2021.111228. Epub 2021 Jan 13. PMID: 33454595; PMCID: PMC7836924.
20. Nedjimi B. Can trace element supplementations (Cu, Se, and Zn) enhance human immunity against COVID-19 and its new variants? Beni Suef Univ J Basic Appl Sci. 2021;10(1):33. doi: 10.1186/s43088-021-00123-w. Epub 2021 May 17. PMID: 34026905; PMCID: PMC8127438.
21. Khatiwada S, Subedi A. A Mechanistic Link Between Selenium and Coronavirus Disease 2019 (COVID-19). Curr Nutr Rep. 2021 Jun;10(2):125-136. doi: 10.1007/s13668-021-00354-4. Epub 2021 Apr 9. PMID: 33835432; PMCID: PMC8033553.
22. Samad N, Sodunke TE, Abubakar AR, Jahan I, Sharma P, Islam S, et al. The Implications of Zinc Therapy in Combating the COVID-19 Global Pandemic. J Inflamm Res. 2021 Feb 26;14:527-550. doi: 10.2147/JIR.S295377. PMID: 33679136; PMCID: PMC7930604.
23. Wessels I, Rolles B, Slusarenko AJ, Rink L. Zinc deficiency as a possible risk factor for increased susceptibility and severe progression of Corona Virus Disease 19. Br J Nutr. 2021 Mar 1:1-19. doi: 10.1017/S0007114521000738. Epub ahead of print. PMID: 33641685; PMCID: PMC8047403.
24. Anuk AT, Polat N, Akdas S, Erol SA, Tanacan A, Biriken D, et al. The Relation Between Trace Element Status (Zinc, Copper, Magnesium) and Clinical Outcomes in COVID-19 Infection During Pregnancy. Biol Trace Elem Res. 2020 Nov 24:1–10. doi: 10.1007/s12011-020-02496-y. Epub ahead of print. PMID: 33236293; PMCID: PMC7685187.
Trends in Pharmaceutical Sciences
Volume 7, Issue 3
September 2021
Pages 153-160

Files

Share

How to cite

Statistics